ArticleBritish journal of haematology2026

Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort.

Umut Yılmaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.